BRIDGEWAY CAPITAL MANAGEMENT, LLC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 37 filers reported holding UNUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$445,000
+411.5%
190,0000.0%0.01%
+400.0%
Q2 2020$87,000
+357.9%
190,000
+322.2%
0.00%
Q1 2020$19,000
-40.6%
45,0000.0%0.00%
Q4 2019$32,000
-50.8%
45,0000.0%0.00%
-100.0%
Q3 2019$65,00045,0000.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$4,840,0007.97%
CHI Advisors LLC 790,805$1,139,0001.11%
New Leaf Venture Partners, L.L.C. 1,795,545$2,586,0000.78%
SECTORAL ASSET MANAGEMENT INC 1,519,174$2,188,0000.38%
Novo Holdings A/S 473,441$682,0000.12%
WEDBUSH SECURITIES INC 33,135$48,0000.01%
OXFORD ASSET MANAGEMENT LLP 100,000$144,0000.00%
WASATCH ADVISORS LP 254,449$366,0000.00%
Tower Research Capital LLC (TRC) 21,602$31,0000.00%
FIL Ltd 783,423$1,128,0000.00%
View complete list of UNUM THERAPEUTICS INC shareholders